• Long-Term Safety and Efficacy of Oral Ribitol in Participants with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I/R9)

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Germany Italy The Netherlands Norway
  • Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    France Germany Italy Spain
  • Efficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Greece +3
  • Long‑Term Effects of Sirolimus on Volume and Color of Port‑Wine Stain in Patients with Vascular Malformation Undergoing Surgery and Laser Therapy

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway
  • Phase II Study of Teclistamab Plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma After 1–3 Prior Therapies

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Estonia Finland Norway
  • Evaluation of [68Ga]Ga-FAPI-46 PET Imaging for Staging and Detecting Disease Progression in Patients with Transthyretin Cardiac Amyloidosis

    Not yet recruiting

    2 1 1
    Investigated diseases:
    France
  • A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

    Not yet recruiting

    3 1
    Austria Belgium Bulgaria France Germany Greece +4
  • Phase 2 Study of Durvalumab + Tremelimumab with Lenvatinib vs Durvalumab + Tremelimumab Alone in Patients with Unresectable Hepatocellular Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Italy
  • Effect of High‑Dose Thiamine Hydrochloride on Fatigue in Rheumatoid Arthritis Patients: Randomized, Double‑Blind, Placebo‑Controlled Trial

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Croatia Greece

powered by